Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giovanna.gentile@uniroma1.it
Giovanna Gentile
Professore Associato
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
giovanna.gentile@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
ANTI-CANCER DRUGS
2016
Ribavirin transporter [Ent1] polymorphism is a pretreatment predictor of virologic response. the specific role of donor liver transporter
CLINICAL PHARMACOLOGY & BIOPHARMACEUTICS
2016
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2015
Mitochondrial myopathy and comorbid major depressive disorder. effectiveness of dTMS on gait and mood symptoms
GENERAL HOSPITAL PSYCHIATRY
2015
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population
EXPERT REVIEW NEUROTHERAPEUTICS
2015
Genotype–phenotype correlations in 5-fluorouracil metabolism. a candidate DPYD haplotype to improve toxicity prediction
PHARMACOGENOMICS JOURNAL
2015
Severe and prolonged myelosuppression during concomitant temozolomide and radiotherapy treatment in a patient with glioblastoma multiforme
INTERNATIONAL JOURNAL OF MEDICAL AND PHARMACEUTICAL CASE REPORTS
2015
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy
WORLD JOURNAL OF ONCOLOGY
2015
Single nucleotide polymorphisms related to vitamin B12 serum levels in autoimmune gastritis patients with or without pernicious anaemia
DIGESTIVE AND LIVER DISEASE
2015
Personalized cancer therapy considering cytochrome P450 variability
Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer
2015
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?
WORLD JOURNAL OF ONCOLOGY
2015
« prima
< precedente
1
2
3
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma